1025924-88-2

Upstream product

• 1027154-55-7 Carbonic acid 2-[allyl-(2,2-diethoxy-1-phenyl-ethyl)-carbamoyl]-1-benzyl-1H-indol-7-yl ester methyl ester 
• 1027277-24-2 (9-Benzyl-8-methoxycarbonyloxy-1-oxo-3-phenyl-1,9-dihydro-β-carbolin-2-yl)-acetic acid 
• 1027046-17-8 Carbonic acid 9-benzyl-1-oxo-2-(2-oxo-ethyl)-3-phenyl-2,9-dihydro-1H-β-carbolin-8-yl ester methyl ester 
• 1027960-66-2 Carbonic acid 2-allyl-9-benzyl-1-oxo-3-phenyl-2,9-dihydro-1H-β-carbolin-8-yl ester methyl ester 
• 1026920-30-8 Carbonic acid 1-benzyl-2-chlorocarbonyl-1H-indol-7-yl ester methyl ester 
• 157422-73-6 N-allyl-2,2-diethoxy-1-phenylethylamine 
• 106746-09-2 3(RS)-amino-1,1,1-trifluoro-2(RS)-hydroxy-4-methylpentane hydrochloride 
• 6175-45-7 2,2-diethoxyacetophenone 
• 1026518-97-7 Carbonic acid 9-benzyl-1-oxo-3-phenyl-2-[(3,3,3-trifluoro-2-hydroxy-1-isopropyl-propylcarbamoyl)-methyl]-2,9-dihydro-1H-β-carbolin-8-yl ester methyl ester 

Relevant academic research and scientific papers

Non-peptidic Inhibitors of Human Leukocyte Elastase. 4. Design, Synthesis, and in Vitro and in Vivo Activity of a Series of β-Carbolinone-Containing Trifluoromethyl Ketones

A novel series of human leukocyte elastase (HLE) inhibitors containing the β-carbolinone ring system are reported.The design of these trifluoromethyl ketone-based inhibitors used a combination of structural information obtained from X-ray crystallography